Drug process and regulatory expert PRTM will be acquired by global consultancy PricewaterhouseCoopers. PRTM will join the PwC global advisory practice, among the world's largest consultancies. PwC cites operational strategy, execution and business model innovation among PRTM's strengths, which were no doubt attractive also to drugmaker Ranbaxy when it hired the consultancy to help extricate itself from regulatory hot water. Announcement